Company intelligence / Profile preview

Caristo Diagnostics

Oxford, England, United Kingdomcaristo.com ↗
Ownership
Private
Development stage
Commercial
01

Overview

Caristo Diagnostics’ CaRi‑Heart® technology has demonstrated strong clinical adoption across the UK and EU, with more than double year-over-year growth in clinical use as of mid‑2024. The platform provides novel imaging biomarkers for coronary inflammation and plaque burden from routine cardiac CT scans, improving early detection of cardiovascular disease. It has been validated through partnerships with major hospitals and used as a core lab in multi-country phase II trials for pharmaceutical partners. The company’s technology underpinned a successful phase IIa trial monitoring the anti-inflammatory drug Orticumab from Abcentra, presented at ACC24.

Therapeutic areas
CardiovascularEndocrinology
Modalities
Device (AI-powered diagnostic software)Non-pharmacological therapy (diagnostic only)Platform technology (AI imaging analytics)
Industry
Medical Imaging
02

Partnerships

NHS hospitals across the UK including HCA UK, One Welbeck, Cleveland Clinic UK, Mayo Clinic UKCromwell HospitalHooke LondonmyGP ClinicGroupe Prive Hospitalier Ambroise Paré Hartmann (France)Pharmaceutical collaborations including Abcentra (Orticumab trial) and Agepha Pharma

Beyond the preview

Go deeper on Caristo Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Caristo Diagnostics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call